ANDA 75787, held by Sun Pharm Industries. Fluoxetine Hydrochloride.
As of Nov 16, 2026, ANDA 75787 (Fluoxetine), held by Sun Pharm Industries, was first approved by FDA on Jan 29, 2002, with 3 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jan 29, 2002 | Original application | Approved | None posted |
| FluoxetineEQ 10MG BASE · capsule;oral | Fluoxetine Hydrochloride | Discontinued |
| FluoxetineEQ 20MG BASE · capsule;oral | Fluoxetine Hydrochloride | Discontinued |
| Jun 29, 2007 | Supplement 11Labeling | Approved | None posted |
| Jun 29, 2007 | Supplement 12Labeling | Approved | None posted |
| Jun 30, 2005 | Supplement 4Labeling | Approved | None posted |
| Jan 29, 2002 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters